NEW YORK, May 9, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Relmada Therapeutics, Inc. (“Relmada” or the “Company”) (NYSE: RLMD) violated federal securities laws. CURRENT INVESTIGATION DETAILS: Before market opened on October 13, 2022,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.